CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleRevenue is $7.86B, above the global median of $548.88M
- PositionOperating margin is 29.6%, higher than 95% of its Diagnostics & Research peers (median 8.5%)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.63%
Annual Rate
USD 0.01Paid unknown
Payout Ratio
48.0%Sustainable
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
302.29MUSDvs all stocks (USD)
Revenue (TTM)
7.86BEGPvs all stocks (USD)
Profit Margin
16.71%vs Diagnostics & Research peers
Beta
0.4030xvs all stocks
52-Week Change
-5.45%vs all stocks
Forward Annual Dividend Yield
1.63%vs all stocks
Market Capitalization
302.29MUSDvs all stocks (USD)
Enterprise Value
244.73MUSDvs all stocks (USD)
Forward P/E
0.2938xvs Diagnostics & Research peers
Price to Sales (TTM)
0.0385xvs Diagnostics & Research peers
Price to Book (MRQ)
0.0968xvs Diagnostics & Research peers
Enterprise to Revenue
0.0312xvs Diagnostics & Research peers
Enterprise to EBITDA
0.0842xvs Diagnostics & Research peers
Gross Margin
46.64%vs Diagnostics & Research peers
Profit Margin
16.71%vs Diagnostics & Research peers
Operating Margin
29.62%vs Diagnostics & Research peers
Return on Assets (TTM)
18.92%vs Diagnostics & Research peers
Return on Equity (TTM)
36.76%vs Diagnostics & Research peers
Revenue (TTM)
7.86BEGPvs all stocks (USD)
Revenue per Share (TTM)
13.51EGPUpdated Sep 27, 2026Quarterly Revenue Growth
42.00%vs Diagnostics & Research peers
Gross Profit (TTM)
3.35BEGPvs all stocks (USD)
EBITDA (TTM)
2.46BEGPvs all stocks (USD)
Net Income (TTM)
1.26BEGPvs all stocks (USD)
Quarterly Earnings Growth (YoY)
25.50%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
1.90BEGPvs all stocks (USD)
Levered Free Cash Flow (TTM)
20.98MEGPvs all stocks (USD)
Forward Annual Dividend Rate
0.0100USDUpdated Sep 27, 2026Forward Annual Dividend Yield
1.63%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
47.99%vs Diagnostics & Research peers
Minority Interest (Equity)
747.26MEGPFY2025 · Dec 31, 2025Revenue
7.86BEGPFY2025 · Dec 31, 2025Cost of Goods Sold
4.50BEGPFY2025 · Dec 31, 2025Gross Profit
3.35BEGPFY2025 · Dec 31, 2025Operating Income
2.12BEGP41.09M · vs all stocks (USD)
Pre-tax Income
2.12BEGPFY2025 · Dec 31, 2025Income Tax Expense
816.89MEGPFY2025 · Dec 31, 2025Net Income
1.30BEGPFY2025 · Dec 31, 2025EBIT
2.33BEGPFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.91BEGPFY2025 · Dec 31, 2025Selling, General & Administrative
632.84MEGPFY2025 · Dec 31, 2025Other Operating Expenses
1.93MEGPFY2025 · Dec 31, 2025Non-operating Interest Income
222.91MEGPFY2025 · Dec 31, 2025Non-operating Interest Expense
208.50MEGPFY2025 · Dec 31, 2025EPS (Basic)
2.17EGPFY2025 · Dec 31, 2025EPS (Diluted)
2.17EGPFY2025 · Dec 31, 2025Basic Shares Outstanding
581.33MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
581.33MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-39.46MEGPFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EGPFY2025 · Dec 31, 2025Operating Cash Flow
1.53BEGPFY2025 · Dec 31, 2025Free Cash Flow
1.11BEGPFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.67BEGPFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.12BEGPFY2025 · Dec 31, 2025Stock-based Compensation
-1.38MEGPFY2025 · Dec 31, 2025Other Non-cash Items
-28.39MEGPFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-446.25MEGPFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-110.56MEGPFY2025 · Dec 31, 2025Capital Expenditures
-425.85MEGPFY2025 · Dec 31, 2025Net Intangibles (CF)
-84.89MEGPFY2025 · Dec 31, 2025Net Acquisitions
-340.00MEGPFY2025 · Dec 31, 2025Purchase of Investments
-882.53MEGPFY2025 · Dec 31, 2025Sale of Investments
965.00MEGPFY2025 · Dec 31, 2025Net Investing Cash Flow
-683.38MEGPFY2025 · Dec 31, 2025Long-term Debt Issuance
383.46MEGPFY2025 · Dec 31, 2025Long-term Debt Payments
-219.82MEGPFY2025 · Dec 31, 2025Common Stock Repurchase
0.00EGPFY2025 · Dec 31, 2025Common Dividends Paid
-535.14MEGPFY2025 · Dec 31, 2025Other Financing Charges
23.81MEGPFY2025 · Dec 31, 2025Net Financing Cash Flow
-347.69MEGPFY2025 · Dec 31, 2025Shares Outstanding
581.33MSharesUpdated Sep 27, 2026Float Shares
124.82MSharesUpdated Sep 27, 2026% Held by Insiders
58.73%vs all stocks
% Held by Institutions
45.04%vs all stocks
Total Cash (MRQ)
1.13BEGPvs all stocks (USD)
Total Debt (MRQ)
1.68BEGPvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3575xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.67xvs Diagnostics & Research peers
Book Value per Share (MRQ)
5.37EGPUpdated Sep 27, 2026Total Assets
8.60BEGP166.22M · vs all stocks (USD)
Total Current Assets
3.95BEGPFY2025 · Dec 31, 2025Total Liabilities
4.46BEGPFY2025 · Dec 31, 2025Total Non-current Assets
4.64BEGPFY2025 · Dec 31, 2025Total Non-current Liabilities
1.77BEGPFY2025 · Dec 31, 2025Total Current Liabilities
2.70BEGPFY2025 · Dec 31, 2025Cash
363.26MEGPFY2025 · Dec 31, 2025Cash Equivalents
1.31BEGPFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.67BEGPFY2025 · Dec 31, 2025Other Short-term Investments
454.29MEGPFY2025 · Dec 31, 2025Accounts Receivable
996.49MEGPFY2025 · Dec 31, 2025Inventory
424.43MEGPFY2025 · Dec 31, 2025Accounts Payable
563.45MEGPFY2025 · Dec 31, 2025Short-term Debt
418.71MEGPFY2025 · Dec 31, 2025Long-term Debt
1.19BEGPFY2025 · Dec 31, 2025Common Stock (Book)
1.04BEGPFY2025 · Dec 31, 2025Retained Earnings
2.60BEGPFY2025 · Dec 31, 2025Total Shareholders' Equity
4.13BEGP79.88M · vs all stocks (USD)
52-Week Low
0.4400USDUpdated Sep 27, 202652-Week High
0.8350USDUpdated Sep 27, 202652-Week Change
-5.45%vs all stocks
Beta
0.4030xvs all stocks
50-Day MA
0.5390USDUpdated Sep 27, 2026200-Day MA
0.5874USDUpdated Sep 27, 2026Avg 10-Day Volume
92.47KSharesUpdated Sep 27, 2026Avg 30-Day Volume
66.71KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
0.0500EGPUpdated Sep 27, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 29.6%, higher than 95% of its Diagnostics & Research peers (median 8.5%)Significant
Operating margin: 0.30Industry median: 0.09Industry P95: 0.29Peers compared: 30.00
Return on equity is 36.8%, higher than 95% of its Diagnostics & Research peers (median 1.2%)Significant
Return on equity: 0.37Industry median: 0.01Industry P95: 0.30Peers compared: 30.00
Price-to-book is 0.1×, lower than 95% of its Diagnostics & Research peers (median 2.38×)Notable
Price-to-book: 0.10Industry median: 2.38Industry P5: 0.60Peers compared: 30.00
Financial Health
Altman Z-Score 4.53: safe zoneNotable
Altman Z-Score: 4.53
High earnings qualityNotable
Earnings Quality Score: 1.00
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $7.86B, above the global median of $548.88MNotable
Revenue (USD): 7,855,407,000Global Median: 548,883,780.48
Levered free cash flow is $20.98M, above the global median of $18.73MNotable
Levered free cash flow (USD): 20,982,788Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Sichuan Golden Summit Group Joint-stock Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Benli Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Safety Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleRisk
Jiangsu Topfly New Material Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
VT Industrial Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Improve Medical Instruments Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Kung Long Batteries Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Haixin Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Anton Oilfield Services Group
Tier 1ProductionThroughput-Bound ConversionRule
Beijing Jiaoda Signal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Curves Holdings Co., Ltd.
5 interpretationsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
Harmony Biosciences Holdings, Inc.
5 interpretationsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
IMI plc
5 interpretationsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin